Janux Therapeutics
JANX
JANX
54 hedge funds and large institutions have $362M invested in Janux Therapeutics in 2023 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 18 increasing their positions, 14 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0.08% less ownership
Funds ownership: 73.01% → 72.94% (-0.08%)
2% less capital invested
Capital invested by funds: $370M → $362M (-$7.41M)
Holders
54
Holding in Top 10
–
Calls
$201K
Puts
$17K
Top Buyers
| 1 | +$29.9M | |
| 2 | +$3.12M | |
| 3 | +$2.85M | |
| 4 |
Millennium Management
New York
|
+$1.24M |
| 5 |
Cerity Partners
New York
|
+$723K |
Top Sellers
| 1 | -$40.2M | |
| 2 | -$924K | |
| 3 | -$671K | |
| 4 |
Morgan Stanley
New York
|
-$178K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$154K |